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Abstract
The main objective of this prospective longitudinal study was to investigate bidirectional
associations between adolescent cannabis use (CU) and neurocognitive performance in a
community sample of 294 young men from ages 13 to 20 years. The results showed that in early
adolescence, and prior to initiation to CU, poor short-term and working memory, but high verbal
IQ, were associated with earlier age of onset of CU. In turn, age of CU onset and CU frequency
across adolescence were associated with (a) specific neurocognitive decline in verbal IQ and
executive function tasks tapping trial and error learning and reward processing by early adulthood
and (b) lower rates of high-school graduation. The association between CU onset and change in
neurocognitive function, however, was found to be accounted for by CU frequency. Whereas the
link between CU frequency across adolescence and change in verbal IQ was explained (mediated)
by high school graduation, the link between CU frequency and tasks tapping trial and error
learning were independent from high school graduation, concurrent cannabis and other substance
use, adolescent alcohol use, and externalizing behaviors. Findings support prevention efforts
aimed at delaying onset and reducing frequency of CU.
Cannabis is the most widely used substance worldwide (Degenhardt & Hall, 2012;
Degenhardt, Stockings, Patton, Hall, & Lynskey, 2016; Hall et al., 2016) and is perceived,
among adolescents, as less harmful than other substances (Johnston, O’Malley, Bachman, &
Schulenberg, 2013). The debate surrounding the beneficial and harmful effects following
recreational or medical use still continues, especially as adolescence is viewed as a period of
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vulnerability for brain development, and cannabis as a threat to this development. There is
evidence to suggest that the adolescent brain may be particularly vulnerable to the
neurotoxic effects of substances, especially with regard to neurocognitive functioning
(Rubino et al., 2009; Schweinsburg, Brown, & Tapert, 2008). This is because adolescence
represents a critical period of neurodevelopment, characterized by synaptic pruning and
increased myelination, particularly in cortical and frontal areas of the brain. Moreover, the
endocannabinoid system appears to be involved in the regulation of the key
neurodevelopmental processes of synaptic pruning and myelination (Lubman, Cheetham, &
Yucel, 2015; Paus, 2005, 2007), suggesting that the introduction of exogenous cannabinoids
during adolescence could disrupt normal brain development and, in turn (Lubman et al.,
2015; Rubino & Parolaro, 2016), have an impact on cognitive function (Broyd, van Hell,
Beale, Yucel, & Solowij, 2016; Volkow et al., 2016). Some support for this has come from
animal and human studies showing that cannabis exposure during adolescence was
associated with morphological and connectivity changes in brain structures that are densely
populated with cannabinoid receptors (e.g., in the prefrontal cortex [PFC], hippocampus,
and cerebellum; Burns et al., 2007; Realini, Rubino, & Parolaro, 2009; Rubino et al., 2015).
Although the mediating role of these structural/morphological changes resulting from
cannabis use (CU) and cognitive function has yet to be demonstrated, several studies show
that heavy, long-term CU is associated concurrently with impaired neurocognitive function
(NCF) in animals and human adults (e.g., Fried, Watkinson, & Gray, 2005; Lubman et al.,
2015; Rubino & Parolaro, 2016; Verrico, Gu, Peterson, Sampson, & Lewis, 2014).
Similarly, studies comparing adolescents using cannabis on a regular basis (i.e., weekly) to
controls reported that they have reduced processing speed (Gruber, Sagar, Dahlgren, Racine,
& Lukas, 2012; Lisdahl & Price, 2012; Medina et al., 2007) and perform worse on tasks
assessing attention (Hanson et al., 2010; Lisdahl & Price, 2012; Mathias et al., 2011; Medina
et al., 2007), verbal memory (Hanson et al., 2010; Medina et al., 2007), intelligence
(Harvey, Sellman, Porter, & Frampton, 2007), and executive function (Grant, Chamberlain,
Schreiber, & Odlaug, 2012; Harvey et al., 2007; Lisdahl & Price, 2012; Mathias et al., 2011;
Medina et al., 2007). Some suggest that these effects may persist even after extended periods
of abstinence (Bolla, Brown, Eldreth, Tate, & Cadet, 2002; Broyd et al., 2016; Crean, Crane,
& Mason, 2011; Lyons et al., 2004), but this is still debated as meta-analyses showed that all
non-acute, residual effects of CU on cognitive performance in adults and adolescents were
no longer detectable after 1 month or more of abstinence (Schreiner & Dunn, 2012; Schulte
et al., 2014). Nonetheless, most human studies contributing to this debate are cross-sectional
case-control or retrospective, without proper assessment of cognitive function prior to CU
onset. This is an important limitation, as presubstance use performance on certain IQ and
executive function tasks (assessed, e.g., at 12–14 years) have been shown to be linked with
later substance use onset and increased CU frequency (Castellanos-Ryan, Séguin, Vitaro,
Parent, & Tremblay, 2013; Squeglia, Jacobus, Nguyen-Louie, & Tapert, 2014; White &
Batty, 2012) or be associated with change in CU frequency and severity (Cousijn et al.,
2014). In the absence of clinical trials, prospective longitudinal studies that include pre- and
postdrug use neurocognitive assessments are needed to clarify temporal associations
between CU and neurocognitive development and guide prevention efforts.
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Only a few studies have examined the prospective specific association between adolescent
CU and NCF. One longitudinal study following adolescents with substance use disorders,
including CU disorder, over time, found that greater cumulative CU over an 8-year follow-
up period was associated with poorer attention functioning (Tapert, Granholm, Leedy, &
Brown, 2002). However, although specific effects of CU were examined, authors caution
that their findings cannot be attributed solely to any one substance, as polysubstance use was
the norm rather than the exception in that sample. In another study, by Fried et al. (2005),
concurrent chronic, but not former, heavy cannabis users showed lower scores on IQ (d ≈
0.29) and memory (d ≈ 0.30) and faster processing speed (d ≈ 0.44) at ages 17–20 years
relative to nonusers, adjusting for pre-CU onset neurocognitive performance (9–12 years).
However, chronic CU was based on retrospective reports, and it is unclear if early onset of
use was specifically related to neurocognitive decline beyond the effects of concurrent use.
In contrast, a recent prospective longitudinal study by Meier et al. (2012) showed that
persistent CU over a 20-year period across young adulthood (18–38 years) was associated
with a global decline in IQ and neurocognitive performance from ages 13 to 38 years (d =
0.38). In that study, the association between persistent CU and neurocognitive decline
remained when controlling for education, personality, other persistent substance use (SU)
and socioeconomic status (SES; Moffitt, Meier, Caspi, & Poulton, 2013), but only for those
whose persistent CU disorder was already present at 18 years. Further, secondary analyses
on a small subsample showed that significant decline in NCF was still detectable in early
users who reported infrequent (N = 17) CU in the year prior to testing in adulthood. Thus, in
contrast to the findings of two meta-analyses (Schreiner & Dunn, 2012; Schulte et al., 2014),
Meier et al.’s findings suggest that the decline in NCF was independent of frequent
concurrent use (i.e., it did not recover with abstinence), and the authors question if onset of
frequent use before age 19 may have detrimental and potentially irreversible effects on brain
development in the long term. In sum, further studies are still needed not only because of the
contrasting results between studies of adolescence and adulthood but also because the
particular findings reported by Meier et al. (2012) were based on a small subsample of
participants.
Furthermore, independent of potential neurotoxic effects of CU on the developing brain, the
onset of CU is thought to alter a youth’s developmental trajectory in several ways.
Adolescents who use cannabis regularly not only tend to have higher rates of early-onset
behavioral problems (Flory, Lynam, Milich, Leukefeld, & Clayton, 2004; Heron et al., 2013;
Windle & Wiesner, 2004), social adversity (von Sydow, Lieb, Pfister, Hofler, & Wittchen,
2002), and other adolescent SU (Hibell et al., 2012), but also report poor educational
performance and higher school dropout (Fergusson, Boden, & Horwood, 2015; Fergusson,
Horwood, & Beautrais, 2003; Flory et al., 2004; Lynskey, Coffey, Degenhardt, Carlin, &
Patton, 2003; Lynskey & Hall, 2000; McCaffrey, Pacula, Han, & Ellickson, 2010; Silins et
al., 2014; Stiby et al., 2015; Windle & Wiesner, 2004), all of which may confound the
relationships between CU and declines in cognitive function. Measures of school
achievement and high school graduation, in particular, should be taken into account as
adolescent CU is hypothesized to be associated with poor school attainment through its
association with cognitive impairment. However, the opposite could also be true; CU may
be associated with declines in cognitive function, at least in part, through poor school
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attainment (e.g., Silins et al., 2014), which in turn may have an impact on cognitive
development (Brinch & Galloway, 2012).
Within this context we aim to investigate the bidirectional associations between CU and
cognitive function and their association with other important covariates: (a) whether pre-CU
cognitive function is linked to CU onset and later frequency of use; (b) whether cognitive
decline associated with adolescent onset of frequent use may be detected by young
adulthood; and (c) whether it is actual adolescent-onset CU, independent of other factors
(e.g., SES, high school graduation, adolescent alcohol use, externalizing problems,
concurrent SU, and pre-CU cognitive function; Cousijn et al., 2014), that is associated with
neurocognitive impairments. If declines in NCF are a direct result of adolescent CU,
potentially through its neurotoxic effects on the developing brain, then one would
hypothesize that (a) CU would precede a drop in cognitive functioning; (b) an earlier age of
onset and more frequent CU would be associated with a larger cognitive decline; and (c) the
association would persist after adjusting for important covariates, such as other concurrent
SU, pre-CU cognitive function, externalizing problems, and academic achievement.
Furthermore, one might expect that the PFCs would be especially likely to be involved, as
the PFCs have a high density of cannabinoid receptors and continue to develop during
adolescence. Therefore, one could hypothesize that (d) CU during adolescence would be
associated with larger declines in cognitive function related to prefrontal cortices of the
brain (e.g., performance on self-ordered pointing and conditional association tasks
associated with mid- and posterior–dorsolateral frontal lobes, respectively) more than in
function related to other brain areas (e.g., performance on paired associates learning and
digit span tests associated with the hippocampus and medial temporal lobes). Alternatively,
if associations between CU and cognitive decline do not persist after controlling for
covariates, and there is evidence that academic achievement and/or other factors account for
these associations, then results would provide support for other, more social, mechanisms by
which CU and declines in cognitive function are associated. These are all important
unresolved questions for planning prevention. We have addressed these questions in a
prospective longitudinal design that assessed CU frequency yearly across adolescence (14–
17 years) and NCF twice, in early adolescence and early adulthood.
Materials and Methods
Sample
The 294 young men who participated in this study were a sub-sample of the Montreal
Longitudinal and Experimental Study of Low SES boys (MLES). In the spring of 1984,
1,037 boys attending the last year of kindergarten (M age = 6.1 years) were recruited from
schools in low-SES neighborhoods of Montreal. For further information on recruitment and
selection criteria of the MLES sample, see Vitaro, Brendgen, Pagani, Tremblay, and McDuff
(1999) and Tremblay, Pihl, Vitaro, and Dobkin (1994). Sex (boys), ethnicity (Caucasian),
and SES (low to middle SES) were homogeneous as a result of the selection procedure.
Boys were then assessed annually from 10 to 17 years and again at 20 years. This study was
approved by the University of Montreal Institutional Review Board, with participation in the
study requiring both parental consent and child assent. The 294 young men included in this
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study were selected for neurocognitive testing when they were on average 20 years of age
(range = 18.47–22.02), based on trajectories of teacher-rated physical aggression and
hyperactivity scores across childhood and adolescence; an attempt was made to recruit equal
numbers of high and low scorers. Four hundred and ninety-four participants were identified
and contacted over a period of 18 months until a target number of 300 participants were
recruited. Three hundred and four young men (151 low aggressive and hyperactive, 87 high
aggressive and hyperactive, and 66 high aggressive or high hyperactive) originally provided
consent for neurocognitive testing. However, one participant violated drug/alcohol
abstinence restrictions for testing and could not be rescheduled (for further information
about selection and recruitment of this subsample, see Séguin, Nagin, Assaad, & Tremblay,
2004). Another 4 participants were excluded from the current analyses because of
insufficient CU data; all participants included in this study provided reliable cannabis and
other SU data at a minimum of three time points across adolescence (out of five: 13–17
years), and completed at least two of the neurocognitive tasks of interest at 20 years: digit
span backward (n = 300), self-ordered pointing task (SOP, n = 300), conditional association
task (CAT, n = 298), and a card playing task (CAPT, n = 232). A further 5 participants were
excluded because they reported using cannabis before the first measurement of NCF, that is,
13 years, which served to control for NCF prior to CU. This subsample did not differ
significantly from the larger sample for whom SU data was available on alcohol use
frequency, t (886) =0.12, p = .91; CU frequency, t (886) =0.42, p =.68; or number of
substances tried, t (886) = 0.12, p = .91, across adolescence (averaged across 13 to 17 years).
Séguin et al. (2004) previously showed that this subsample was also comparable to the
larger sample on measures of hyperactivity, conduct disorder, and delinquency across
adolescence. Within this sub-sample, missing data across adolescence was only predicted by
verbal IQ at 13 years (odds ratio [OR] =0.82, p < .05), with lower IQ scores being associated
with higher likelihood of missing data, but not by other early adolescence cognitive
variables, family risk, academic achievement, or externalizing problems. Finally, 43% of the
boys in this sample used cannabis at some point during adolescence. Mean use among
adolescent cannabis users was 3.19 (SD = 1.50, range = 1–7), equivalent to using cannabis 3
to 5 times in the past year, and 51% used cannabis at 20 years of age (mean use among adult
cannabis users = 3.54, SD = 0.50, range = 1–4), equivalent to using cannabis “very often.”
See Table 1 for further sample characteristics and descriptive variables.
Instruments and procedure
Adolescent and adult cannabis and other SU frequency—Cannabis, tobacco use,
and alcohol use frequency over the last 12 months were assessed annually from ages 13 to
17 years using the Personal Experience Screening Questionnaire (PESQ; Winters, 1992);
each rated on a 7-point scale: from never (0) to 40 or more times (6; see Table 2 for CU
frequency by age; skewness ranged between 1.00 and 2.23; kurtosis ranged between –0.68
and 3.84). The PESQ is one of the most widely used adolescent SU screening tools
worldwide, and has been shown to have good content, construct and criterion validity in
normative, juvenile offending and drug-abusing populations (Winters, 1992, 2003). An age
of onset variable was computed identifying the age participants were when they first used
cannabis; participants who had not reported having used cannabis as of the final adolescent
assessment (age 17) were coded as initiating CU in the following year (i.e., 18 years). This
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procedure is preferable to dropping these participants from the analysis, and is commonly
used in prospective longitudinal studies of SU (e.g., Hawkins et al., 1997). Alcohol use and
tobacco use were averaged across 13 to 17 years and used as covariates in the final model
(Model 4). Cannabis and other SU at 20 years were also assessed with the PESQ (Winters,
1992), and tobacco use frequency over the last 12 months was assessed on a 4-point scale:
never, sometimes, once a week, and many times per week.
Because age of onset and frequency measures of CU at each time point were strongly
correlated in this sample (r > –.65), a residual score of age of onset (adjusting for its
covariance with average CU frequency from 14 to 17 years) was created and entered into
models in which CU frequency and age of onset were entered together as predictors.
NCF—NCF was indexed through a series of validated measures assessing abilities related to
executive function, such as short-term and working memory, planning, trial and error
learning, and IQ. To evaluate differential effects CU may have on distinct brain areas, the
neurocognitive battery included a number of test tapping cognitive functioning related to
different regions of the brain: working memory, planning, and trial and error learning are
functions associated with frontal brain areas (Petrides, 1990; Petrides, Alivisatos, Evans, &
Meyer, 2013); short-term memory is associated with functioning in the hippocampus and
medial temporal lobes; and IQ is associated with broader functioning in a wider brain
network, which includes the frontal and parietal lobes (Colom, Karama, Jung, & Haier,
2010).
The paired associates learning (PAL) and digit span (DS) subtests (forward and backward)
of the Wechsler Memory Scales—Revised (Wechsler, 1987) tap short-term memory
functions often associated with the hippocampus and medial temporal lobe. During the PAL,
participants are asked to listen to easy or difficult word pairs, and then asked, after the first
word of a pair is provided, to cue recall for the second word. The DS task requires repeating
digits in increasing spans, first in the right order (forward), followed by a backward order.
Number randomization (NR) and the SOP (Petrides et al., 1993), tap working memory
functions associated with the middorsolateral frontal lobe. In the NR task, a range of
numbers is provided, and participants must select all numbers without repeating a digit,
using a pattern, or sequence more than two consecutive numbers. During the SOP,
participants are shown 12 arrays of the same 12 stimuli arranged differently in each array,
and asked to select a new stimulus in each array. Repetitions are counted as errors. CATs
(Petrides, 1990) tap working memory, strategic planning functions, and an ability to learn
associations between two arbitrary visual stimuli by trial and error: functions related to the
posterior–dorsolateral frontal lobe. The CAT requires inductive reasoning, or learning by
trial and error, to discover predetermined patterns of association between a color and an
abstract symbol or a button and a light. The SOP (abstract and concrete forms) and CAT
tests were administered in computerized form at age 20 years (Séguin et al., 2004), which
differ from the noncomputerized versions administered at age 14 years (Séguin, Pihl,
Harden, Tremblay, & Boulerice, 1995). The main difference lies in that scoring accuracy is
increased and experimental error is reduced in the computerized forms, but versions do not
differ in the construct and outcomes measured, as exemplified by their strong correlations
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across versions (and time): SOP r = .55, and CAT r = .52 (correlations among all
neurocognitive tasks across time can be found in online-only supplementary Table S.1).
A trial and error learning CAPT, adapted by Newman, Patterson, and Kosson (1987),
assessing response perseveration (i.e., the inability to modulate default responding in light of
motivationally significant cues) and reward/punishment processing, functions related to the
dorsolateral and orbital–frontal cortices (OFC), was also completed. That task has been
extensively validated in the study of externalizing behavior problems and in this sample
(Séguin, Arseneault, Boulerice, Harden, & Tremblay, 2002; Séguin, Arseneault, &
Tremblay, 2007). The CAPT is a computer-controlled behavioral laboratory task in which
participants are asked to turn over cards, one at a time, from a deck of cards. Each time they
turn over a card they will either win or lose money (5 cents). The task is designed to create a
response set with the help of an initially high rate of rewards, but as the game progresses,
responding is gradually followed by monetary loss. Participants were instructed to play until
they decided to stop and were not given any goals or suggestions that could have biased
their playing strategy.
Finally, a verbal IQ estimate at age 20 was obtained with the French equivalent of the
vocabulary subtests of the Wechsler Adult Intelligence Scale, the Épreuve Individuelle
d’Habile Mentale (Chevrier, 1989), and the age 13 years verbal IQ estimate was obtained
from a sentence completion task (Veroff, McClelland, & Marquis, 1971).
The variables that code for errors (SOP, CAT, and CAPT) were sign reversed in regression
and path analyses so that higher scores on any measure indicates better ability. Task
instructions for the vocabulary, DS, PAL, NR, and CAT have been published elsewhere
(Barker et al., 2011; Séguin et al., 2004), as have instructions for the card-playing task
(Séguin et al., 2002) and for verbal IQ (Séguin, Boulerice, Harden, Tremblay, & Pihl, 1999).
Demographic variables and potential confounders—A measure of family risk at
age 6 was included as a covariate index of SES in all analyses, because it has been
associated with both SU (Hayatbakhsh, Najman, Jamrozik, Mamun, & Alati, 2006) and NCF
(Lovallo et al., 2013). This index tapped parental age at birth of first child, occupational
status, education, and family status (intact or nonintact; Tremblay et al., 1991). Academic
achievement from ages 13 to 15 was assessed with teacher-reported global academic
performance, and in adulthood, with a dichotomous measure of whether participants had
been awarded a high school diploma, which was confirmed by the Ministry of Education of
Quebec (see Boisjoli, Vitaro, Lacourse, Barker, & Tremblay, 2007, for further details).
Teacher-rated externalizing problems (i.e., attention-deficit/hyperactivity disorder and
conduct disorder symptoms, including physical aggression) were assessed with the Social
Behavior Questionnaire (Tremblay et al., 1991), with which teachers were asked to rate
participant symptoms on a 3-point scale (never–often) at yearly intervals from ages 13 to 15.
An average score across 13–15 years was computed for each set of symptoms. Table S.2 in
the online-only supplementary materials shows correlations between cognitive measures and
these covariates, indicating that performance on all cognitive measures in early adolescence
and at 20 years, except for the CAPT, was associated negatively with family risk and
externalizing problems and positively with academic achievement measures. Poor
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performance on the CAPT at 13 years was associated with higher family risk and lower
academic achievement at 13 to 15 years, but not with externalizing problems or high school
graduation; performance on the CAPT at 20 years was not significantly associated with any
non-SU covariates.
Statistical analyses
An unconditional latent growth curve model of CU frequency was conducted to estimate the
initial level (intercept) and the systematic change (slope) in CU frequency between the ages
of 14 and 17 years. In the latent growth curve model framework, when a model is centered
at the first time point (i.e., 14 years), the initial levels of CU frequency are modeled with the
intercept (which varies across participants), and the systematic change over time; for
instance a linear increase in CU frequency from 14 to 17 years, is modeled by a slope
(which also varies across participants).
Next, a conditional latent growth model was conducted in which CU age of onset and CU
frequency intercept and slope factors were associated with early adolescent NCF (at 13–14
years) indexed through the measures described earlier. Finally, several path models were
conducted to examine whether variability in cannabis age of onset, CU frequency at 14 years
(intercept factor), and increases in CU frequency from 14 to 17 years (slope factor) were
associated with change in NCF in early adulthood (20 years) from early adolescence (13–14
years; using change scores; analyses using neurocognitive residualized scores and baseline
scores as covariates were also conducted, yielding equivalent results). CU age of onset and
CU frequency were entered into models separately (Models 1 and 2) and simultaneously
(Models 3 and 4) to examine general and unique links of these aspects of CU on change in
cognitive function. All models were adjusted for the effect of potential confounders:
childhood adversity, academic achievement from 13 to 15 years verbal IQ at 13 years (and
any cognitive function in early adolescence that was shown to be associated with later CU),
age at adult testing, and concurrent cannabis, tobacco, and other SU in adulthood (20 years;
Models 1–4). The last model further adjusted for high school graduation, adolescent alcohol
use, and tobacco use frequency and externalizing problems (Model 4).
Analyses were conducted using Mplus version 6.11 (Muthén & Muthén, 1998–2009) using
maximum likelihood estimation with robust standard errors (MLR). There is ongoing debate
about how ordinal variables of more than five ordered categories, with skewness and
kurtosis ≤2 and ≤7, respectively, should be handled. Thus, several latent growth curve
models of CU frequency were conducted using MLR and weighted least squares estimators.
As results were similar across methods, mirroring previous simulation studies (e.g.,
Rhemtulla, Brosseau-Liard, & Savalei, 2012), only models using MLR are reported. Full
information maximum likelihood was used to account for missing data. Tests of goodness of
fit included the comparative fit index (Bentler, 1990), the root mean square error of
approximation (Browne & Cudeck, 1993), and the standardized root mean residual. Finally,
the Benjamini–Hochberg procedure (Thissen, Steinberg, & Kuang, 2002) was used to
correct for multiple testing in all analyses. Measures, data preparation, and analyses are
further described in the Method section of supplementary online material.
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Results
Preliminary analysis: Unconditional latent growth model of CU frequency
Several growth curve models were conducted to assess which growth function fit the CU
frequency data best (see the Preliminary analysis section in the supplementary material). A
growth model where growth was assumed to be linear across the first three time points (14–
16 years), but left to be freely estimated for the last time point (17 years; see Figure 1), fit
the CU data best (χ2 =10.6, df = 4, comparative fit index = 0.97, root mean square error of
approximation = 0.07, standardized root mean square residual = 0.06) and showed that
growth between time points 3 (16 years) and 4 (17 years) was smaller than at other time
points (with the freely estimated loading resulting in 2.40 instead of a loading of 3.00, which
is to be expected if growth was linear). Growth curve factor means (intercept = 0.29, slope =
0.48) were significantly different from zero at p <.001 and showed that there was an overall
tendency for CU frequency to increase from 14 to 17 years. There was also significant
individual variability in the mean initial level of CU at 14 years (intercept = 0.61, p < .01)
and its pattern of change over time (slope =0.39, p < .01). Initial CU at age 14 years did not
correlate significantly with change of CU frequency across adolescence (r = .32, p = .15).
Is cognitive function in early adolescence (13–14 years) associated with CU onset
intercept and later CU frequency slope?
To examine the links between NCF and CU onset and later CU frequency, we included
cognitive variables in early adolescence (13 or 14 years), together with family risk, as
predictors of later CU frequency (intercept and slope factors) and CU onset. The results in
Table 3 show that poor performance on the PAL and SOP tasks, tapping into short-term and
working memory, were associated with earlier onset of CU. In contrast, higher verbal IQ
was associated with both earlier onset and a steeper increase in CU frequency.
Are age of onset and frequency of adolescent CU associated with NCF decline in early
adulthood?
Significant associations between covariates and cognitive function in early adolescence and
at 20 years were found (see Table S.2 in the supplementary material). Of note, high family
risk, externalizing problems, and poor academic achievement were associated with poor
performance on most, if not all, cognitive tasks. In addition, as shown in Table 4 (Model 1),
cognitive performance on verbal IQ, PAL, and SOP tasks in early adolescence, as well as
SU at 20 years were significantly associated with change in performance on many of the
cognitive tasks. The results presented in Table 4 also show that although early age of CU
onset was generally associated with a decline in cognitive function on the vocabulary, SOP,
and CAT (Model 1), this was no longer the case when intercept and slope factors of CU
were taken into account (Model 3, which used the residualized score of age of onset). In
contrast, initial levels of CU frequency at 14 years (intercept factor) remained significantly
associated with a decline in performance on the CAPT task (β = –0.27, p < .001), and a
steeper increase in CU frequency across adolescence (slope factor) remained associated with
a decline in performance on the vocabulary (β = –0.17, p < .01) and conditional association
(β = –0.28, p < .001) tasks after controlling for multiple testing (Model 3). Once we adjusted
for adolescent alcohol and tobacco use frequency, high school graduation, and other
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externalizing behaviors in Model 4, the significant associations between initial levels of CU
frequency at 14 years and the CAPT (β = –0.30, p < .001) and between growth in CU
frequency and the CAT remained (β = –0.21, p < .001; see Figure 2 for a graphical
representation of these results). However, the association between growth in CU frequency
and change in vocabulary was no longer significant; only high school graduation was
significantly associated with change in vocabulary (β = 0.20, p < .001).
Because high school graduation was significantly and negatively associated with growth in
CU frequency (slope factor): B = –0.12, SE = 0.057, OR = 0.54, 95% CI [0.30, 0.97], and
age of onset, B = 0.06, SE = 0.025, OR = 1.34, 95% CI [1.02, 1.73], but not CU frequency at
14 years (intercept factor): B = –0.07, SE = 0.039, OR = 0.83, 95% CI [0.51, 1.34], the
significance of indirect effects from CU frequency slope to change in vocabulary through
high school graduation was tested using the Rmediation program (Tofighi & MacKinnon,
2011). The indirect effect from growth in CU frequency from 14–17 to change in verbal IQ
through high school graduation was significant (slope): ab = –0.163, 95% CI [–0.334, –
0.032].
Is adolescent CU frequency associated with declines in functioning on the CAPT and the
CAT in early adulthood in those that had abstained from CU over 12 months prior to adult
cognitive testing?
In order to investigate whether the effects of initial levels of CU frequency and change
across adolescence (intercept and slope factors) on declines in cognitive function could be
considered long-term residual effects (as opposed to acute effects), analyses were repeated
on the sample of participants that reported no CU over the last 12 months at age 20 (N =
143). Forty adolescents of this subsample had used cannabis across adolescence, but none
with onset before 15 years. Consequently, in the absence of adolescents who used cannabis
at 14 years among this sample of abstainers, we were unable to confirm whether the effect of
CU frequency at 14 years on the CAPT remained once adolescents abstained from CU in
adulthood. However, in those who had abstained from using cannabis 12 months prior to
cannabis testing at 20 years, the increase in CU across adolescence (slope) was still
significantly associated with a decline in conditional association from preadolescence to
early adulthood (B = –0.20, p = .017), suggesting that this association was not only due to
concurrent or continued active CU into adulthood.
Discussion
This study was conducted to examine bidirectional effects between CU and cognitive
function and to determine the extent to which age of onset or frequency of CU across
adolescence were linked to neurocognitive decline between early adolescence pre-CU onset
and early adulthood, after adjusting for key confounds. First, findings suggest that the
relationship between neurocognition and CU may be bidirectional. In early adolescence poor
short-term and working memory, but high verbal IQ, were associated with an earlier age of
onset of CU. In turn, an earlier age of onset and more frequent use at 14 years and across
adolescence were associated with neurocognitive decline by early adulthood. More
specifically, adolescent CU frequency and earlier age of onset were associated not only with
lower rates of high school graduation, controlling for early adolescent academic
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achievement, but also with neurocognitive decline in early adulthood, independently from
high school graduation, concurrent cannabis and other SU, adolescent alcohol, and tobacco
use, and externalizing behaviors. Second, links were not observed globally across all
neurocognitive tasks, but only for verbal IQ and tasks tapping trial and error learning, an
executive function process indexed by the conditional association learning task, and
response perseveration on the CAPT (which also assesses reward processing). Third,
although the results indicate that earlier age of onset was associated with a decline in a few
NCFs, these effects were not independent of frequency of use. Despite an attempt to control
for the high correlation between age of onset and frequency of CU by creating a residual age
of onset score, it may not be possible to examine the true role age of onset plays in cognitive
decline given this high correlation with frequency of use. However, the results suggest that
CU during adolescence was associated with declines in specific cognitive functions through
two different pathways or mechanisms: one more “social” mechanism related to school
engagement, and another more “biological” mechanism related to potential neurotoxic
effects on the adolescent brain.
More specifically, adolescent CU frequency was associated with declines in verbal IQ, but
these effects were accounted for by high school graduation. Accordingly, our findings are
consistent with studies showing that childhood and adolescent-onset mental health and CU
(and other SU) problems are linked with failure to graduate from high school (Breslau et al.,
2008; Lee et al., 2009), a key functional impairment, which in the present study helped
explain the association between CU frequency and a decline in vocabulary by early
adulthood. These results provide some support for the hypothesis that the link between CU
and declines in cognitive function could be at least partially because adolescent cannabis
users are less likely to complete school (e.g., Silins et al., 2014), which in turn has an impact
on their cognitive development (Brinch & Galloway, 2012). Thus, it could be that the link
between CU and declines in verbal IQ operates partly through truancy or low levels of
school engagement (Mokrysz et al., 2016).
Nonetheless, the findings showed that adolescent CU was significantly associated with
declines in performance on two cognitive tasks, the conditional association and CAPT, even
after controlling for high school graduation and a number of other important confounders,
suggesting that declines in performance could potentially be a direct result of CU on the
developing brain. Note that a decline in performance was observed on the only two tasks in
our battery that included a learning component, in this case, learning inductively through
trial and error, a complex cognitive function related to executive function and the prefrontal
cortices of the brain. It is also notable that, although it may be hard to disentangle the effects
of age of onset and frequency of use in this sample, the age of onset of CU was associated
with declines in the CAT (Table 3, Model 1), a finding that was confirmed by group-based
analyses (see supplementary results and Tables S.3 and S.4 in the supplementary material)
showing that participants who used cannabis before the age of 16 reported larger declines in
performance on this task and differed significantly from nonusers. These findings, taken
together with the finding that CU at 14 years (that remained constant across adolescence)
was associated with declines in performance on the CAPT, suggest that age of onset does
matter, providing support for the hypothesis that CU may have more detrimental neurotoxic
effects on the developing brain of adolescents compared to the those on the adult brain. CU
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during adolescence is hypothesized to lead to alterations in synaptic pruning and a disruption
of the development of the PFCs, which have a high density of cannabinoid receptors and
continue to develop during adolescence (Fuhrmann, Knoll, & Blakemore, 201l; Lubman et
al., 2015; Rubino & Parolaro, 2016). This in turn is hypothesized to impact on cognitive
function related to prefrontal cortices more than those related to other brain areas. Indirect
support for this comes from studies showing that early adolescent CU is associated with
poor white matter integrity in the PFC (Becker, Wagner, Gouzoulis-Mayfrank, Spuentrup, &
Daumann, 2010a; Gruber, Dahlgren, Sagar, Gonenc, & Lukas, 2014), decreased cortical
thickness in the superior PFC and frontal cortices (Churchwell, Lopez-Larson, & Yurgelun-
Todd, 2010; Lopez-Larson et al., 2011), and with abnormal brain activation in the PFC and
parietal brain regions (Becker, Wagner, Gouzoulis-Mayfrank, Spuentrup, & Daumann,
2010b; Cheng et al., 2014; Jager, Block, Luijten, & Ramsey, 2010).
Further, effects of CU frequency at 14 years that remained stable across adolescence on
CAPT remained after controlling for change in the CAT (see the Results section in the
supplementary material). This suggests that early frequent CU may also have effects on
reward and punishment processing, possibly leading to a failure to modulate behavior in
light of motivationally significant cues. This is consistent with findings showing that (a)
chronic CU is associated to poor decision making through a decreased sensitivity to loss and
greater sensitivity to gains (Fridberg et al., 2010), and alterations in neural activity related to
the processing of motivation-ally relevant stimuli and errors (Fridberg, Skosnik, Hetrick, &
O’Donnell, 2013); and (b) CU is associated with reduced gray matter in the OFC
(particularly the right medial OFC), a brain region involved in reward processing and
motivation (Churchwell et al., 2010; Filbey et al., 2014).
However, we were unable to confirm whether effects of CU on the CAPT were still
observable in a sample of abstinent adults as all adolescents who had a CU onset at 14 years
(n = 27) continued to use cannabis at 20 years. Thus, it was not possible to confirm whether
the effects of CU frequency at 14 years on decline in performance on the CAPT task were
due to frequent use (using on average 6 or more times per year) at this age that continued
across adolescence or to frequent early adolescent use combined with continued active use
into adulthood. The effects of CU frequency across adolescence on the CAT, however,
remained even in adults who abstained from CU over the 12 months prior to adult cognitive
testing, confirming that these effects are not only attributable to concurrent or continued
active use. This contrasts with conclusions from meta-analyses suggesting that cognitive
deficits may be recoverable after a month of abstinence (Schreiner & Dunn, 2012; Schulte et
al., 2014), but is consistent with findings by Meier et al. (2012), which showed that
persistent moderate- to high-frequency CU from adolescence onward was associated with
declining NCF in middle-aged adults. However, current results differ from Meier et al.
(2012), though, in that they do not support that adolescent CU is associated with global
neurocognitive decline in early adulthood. Instead, they suggest that residual long-term
effects (as opposed to acute, short-term effects that recover with abstinence) of early-onset
and frequent adolescent CU, as defined in this sample as going beyond experimentation or
using 6 times or more over a year, may be limited to NCFs involved in trial and error
learning. Overall, these results suggest that, in addition to academic failure, fundamental life
skills necessary for problem solving and daily adaptation, namely, the capacity to learn from
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trial and error and altering an initially rewarded course of action in motivationally
significant situations, may be affected by early cannabis exposure.
The current findings also highlight the importance of assessing baseline individual
differences in pre-CU cognitive functions and bidirectional associations between cannabis
and cognitive function. For example, we found that poor working memory capacity, which
has been shown to be associated with change in CU frequency and severity (Cousijn et al.,
2014; Squeglia et al., 2014) and other cognitive functions (Carlson, Zelazo, & Faja, 2013),
significantly predicted earlier onset of CU in this sample of boys. This latter methodological
point is possibly important for future research. For example, in this sample, higher IQ, not
lower, was shown to be associated with early onset of CU and a steeper increase in CU
frequency across adolescence. This is not the first study to show that higher IQ is associated
with frequent SU in adolescence (Johnson, Hicks, McGue, & Iacono, 2009; White & Batty,
2012). In another study, which included a different subsample of the MLES study, higher
verbal IQ was also found to predict alcohol use frequency in early adolescence (Castellanos-
Ryan et al., 2013) and is consistent with the hypothesis that some cognitive abilities may
facilitate reward-oriented behaviors, including SU (Hyman, Malenka, & Nestler, 2006).
Taken together, these findings highlight the importance of assessing NCFs more broadly
before the onset of CU, and of conducting longitudinal studies to help clarify bidirectional
effects between CU and neurocognitive functioning.
Still, some limitations of the current study should be noted. First, measures of CU quantity
were unavailable. Future studies should include more sensitive measures of quantity and
frequency over time to better establish dose–response associations between CU and NCF.
Second, no biological measures of drug use were obtained, and CU frequency was gathered
through self-report, which is susceptible to bias and may limit the validity of the data.
However, studies have shown that self-reports are reliable when assessing SU in
adolescence (Clark & Winters, 2002) and hence are useful for clinical practice and research.
Together with guaranteed confidentiality to participants, this should contribute to the
reliability and validity of these data. Third, although the current study adjusted for effects of
alcohol use, concurrent CU, and externalizing problems (Tamm et al., 2014), it did not
adjust for childhood trauma or neglect and other mental health problems that may be
associated to CU and may be linked to neurocognitive development, such as schizophrenia
(Meier et al., 2012, did control for this), depression, mania, anxiety, and suicidality (Tamm
et al., 2014). Fourth, adolescent CU in the current study was assessed during the early 1990s
(1991–1995), before the observed trend over the last 20 years of increases in the potency of
cannabis products (ElSohly et al., 2016; Hall & Degenhardt, 2009). Thus, it is possible that
more potent cannabis products used today, which have a higher content of Δ-9-
tetrahydrocannabinol, may have greater neurotoxic effects on the brain. Fifth and finally, the
current sample was made up entirely of French-speaking boys of European American origin
living in low-SES neighborhoods in Montreal. Thus, replication of these findings is needed
with cannabis available today, including girls, and more diverse populations.
There have been many recent commentaries highlighting some limitations of the literature
on the association between CU and neurocognition, as well as highlighting the need for trials
and longitudinal studies that investigate the effects of CU on the developing brain (e.g.,
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Fuhrmann et al., 2015; Volkow et al., 2016). Although the current study cannot address all
limitations, it does provide further clarity on the potential effects of early frequent CU on
NCF and their specificity, though it does not demonstrate causality. Nonetheless, it provides
an additional basis for improving methodology. In the absence of randomized-controlled
trials, the findings from this prospective longitudinal study provide a clear evidence base for
directing prevention efforts toward delaying the onset and reducing the frequency of CU,
particularly in light of the increasing trend of adolescents viewing CU favorably and less
harmful than other drugs. A number of recent studies have shown that prevention
approaches that target early risk factors for SU, such as childhood disruptive behaviors and
impulsivity, have been effective in delaying the onset and reducing the frequency of alcohol
and drug use during adolescence (Castellanos-Ryan et al., 2013; Conrod, Castellanos-Ryan,
& Strang, 2010).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Unconditional latent growth model of self-reported cannabis use frequency from 14 to 17
years (a) centered at 14 years and (b) the average cannabis use frequency across
adolescence. As depicted by the growth factor (slope) loadings (0, 1, 2, 2.4), frequency of
cannabis use increased steadily (linearly) from 14 to 16 years with the increase becoming
flatter from 16 to 17 years. Can, Cannabis; r, residual variance.
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Figure 2.
Change in response perseveration (card playing task) and working memory, planning, and
trial and error learning (conditional association task) from early adolescence to early
adulthood by adolescent cannabis use scores. In the card playing task, playing more than 75
cards is considered response perseveration (Séguin et al., 2002). Cond Association,
conditional association task.
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Table 1
Neurocognitive scores, demographic, substance use, and control variables in whole sample (N = 294)
Mean SD Min Max
Age 13
 Verbal IQ, correct 9.23 1.93 2 13
 Number randomization, trials 3.41 1.57 0 8
 DS forward, correct 6.52 1,73 1 11
 DS back, correct 5.93 1.44 3 12
Age 14
 SOP, errors 12.01 4.37 3 29
 PAL, correct 24.03 4.47 5 32
 Conditional, errors 78.68 28.23 22 183
CAPT at 13, cards played 71.02 19.89 26 100
Age 20
 Verbal IQ, correct 44.06 11.26 11 76
 Number randomization, trials 5.11 2.27 0 10
 DS forward, correct 8.20 2.17 2 12
 DS back, correct 6.89 2.38 2 12
 SOP, errors 8.39 4.83 0 24
 PAL, correct 26.40 3.63 6 30
 Conditional, errors 49.48 37.43 3 153
 CAPT, cards played 69.80 22.86 26 100
Family risk 6 years 0.32 0.25 0 1
Age at adult testing 20.5 0.65 19.8 22.2
13–15 years
 Academic achievement 3.34 1.33 1 5
 ADHD symptoms 11.5 8.17 0 33
 CD symptoms 1.53 2.17 0 14
14–17 years
 Tobacco use frequency 1.69 0.89 1 4
 Alcohol frequency 2.19 0.71 1 4
20 years
 Cannabis frequency 2.47 1.22 1 4
 Stimulant/hallucinogen use 1.53 0.83 1 4
 Drunkenness 2.58 0.91 1 4
  Rates N %
High school graduation 171 58
Adolescent cannabis users (14–17 years) 142 43
Cannabis users at 20 years 155 53
Tobacco smokers at 20 years 137 46
Alcohol use before 15 years 198 67
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Note: DS, Digit span; SOP, self-ordered pointing; PAL, paired associates learning; CAPT, card playing task; ADHD, attention-deficit/hyperactivity
disorder; CD, conduct disorder.
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Table 2
Endorsement of cannabis use frequency over the last 12 month, and mean cannabis use in full sample and
cannabis users by age
Age
14 (N = 289) 15 (N = 285) 16 (N = 280) 17 (N = 273)
No use (0) 262 (90.7%) 210 (73.7%) 172 (61.4%) 152 (55.7%
Once or twice (1) 8 (2.8%) 27 (9.5%) 25 (8.9%) 32 (11.7%)
3–5 times (2) 1 (0.3%) 13 (4.6%) 18 (6.1%) 9 (3.3%)
6–9 times (3) 6 (2.1%) 5 (1.8%) 13 (4.4%) 11 (4.0%)
10–19 times (4) 5 (1.7%) 12 (4.1%) 17 (5.8%) 16 (5.9%)
20–39 times (5) 3 (1.0%) 3 (1.1%) 10 (3.6%) 13 (4.8%)
40+ times (6) 4 (1.4%) 15 (5.3%) 25 (8.5%) 40 (14.7%)
Mean (SD)
 In full sample 0.30 (1.09) 0.78 (1.64) 1.31 (2.03) 2.66 (2.30)
 In cannabis users 3.22 (1.81) 3.00 (1.95) 3.41 (1.89) 3.74 (2.04)
Note: Cannabis use frequency was rated on the 7-point scale: 0 = no use, 1 = used once or twice, 2 = 3–5 times, 3 = 6–9 times, 4 = 10–19 times, 5 =
20–39 times, 6 = 40 or more times. Percentages are computed within age.
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re 
err
or 
of 
ap
pro
xim
ati
on
 (R
MS
EA
) =
 0.
00
,
co
mp
ara
tiv
e f
it i
nd
ex
 (C
FI)
 = 
1.0
0, 
sta
nd
ard
ize
d r
oo
t m
ean
 sq
ua
re 
res
idu
al 
(SR
MR
) =
 0.
01
; M
od
el 
2: 
χ2
 (3
9) 
= 9
4.4
6, 
RM
SE
A 
= 0
.07
, C
FI 
= 0
.95
, S
RM
R 
= 0
.03
; M
od
el 
3: 
χ2
 (4
1) 
= 1
01
.28
, R
MS
EA
 =
0.0
7, 
CF
I =
 0.
95
, S
RM
R 
= 0
.03
; M
od
el 
fit 
for
 M
od
el 
4: 
χ2
 (5
1) 
= 1
01
.43
, R
MS
EA
 =0
.06
, C
FI 
=0
.96
, S
RM
R 
=0
.02
. A
lth
ou
gh
 on
ly 
pre
sen
ted
 un
de
r M
od
el 
1, 
sta
nd
ard
ize
d c
oe
ffi
cie
nts
 ar
e a
dju
ste
d f
or 
ag
e a
t
tes
tin
g i
n a
du
lth
oo
d; 
fam
ily
 ris
k; 
av
era
ge
 ac
ad
em
ic 
ach
iev
em
en
t 1
3–
15
; v
erb
al 
IQ
 at
 13
; S
OP
 an
d P
AL
 at
 14
; a
nd
 co
nc
urr
en
t c
an
na
bis
, a
lco
ho
l, s
tim
ula
nt,
 an
d t
ob
acc
o u
se 
fre
qu
en
cy
 at
 20
 ye
ars
 in
 al
l
mo
de
ls.
a T
he
 ve
rba
l IQ
 ch
an
ge
 sc
ore
 w
as 
cal
cu
lat
ed
 by
 st
an
da
rdi
zin
g t
he
 se
nte
nc
e c
om
ple
tio
n t
ask
 (v
erb
al 
IQ
) a
t 1
3 y
ear
s (
z s
co
res
) a
nd
 su
btr
act
ing
 it 
fro
m 
sta
nd
ard
ize
d (
z-s
co
red
) v
oc
ab
ula
ry 
sco
res
 at
 20
 ye
ars
.
An
aly
ses
 us
ing
 ch
an
ge
 sc
ore
s c
om
pu
ted
 us
ing
 th
e v
oc
ab
ula
ry 
sub
tes
t a
t 1
5 y
ear
s a
s b
ase
lin
e s
co
res
 w
ere
 eq
uiv
ale
nt 
to 
tho
se 
rep
ort
ed
 he
re 
(di
ffe
rin
g o
nly
 by
 a 
few
 de
cim
als
), w
ith
 an
aly
ses
 yi
eld
ing
eq
uiv
ale
nt 
res
ult
s (
see
 D
ata
 Pr
ep
ara
tio
n a
nd
 St
ati
sti
cal
 A
na
lys
is 
sec
tio
n i
n t
he
 on
lin
e s
up
ple
me
nta
ry 
ma
ter
ial
).
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